Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Borax Europe, a subsidiary of Rio Tinto, is a leading supplier of borates, including high-purity pharmaceutical-grade boric acid and borax decahydrate. The company provides essential chemical ingredients used as excipients, buffering agents, and active pharmaceutical ingredients in products such as ophthalmic solutions, topical creams, and various healthcare applications. Operating as part of the Rio Tinto Borates business, Borax Europe ensures compliance with international pharmacopeia standards (USP, NF, EP) for the global life sciences industry. Their products are critical for pH control and stabilization in a wide range of medical and personal care formulations. The company serves as a key link in the supply chain for boron-based therapeutic developments and established medical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Borax Europe.